New proton beam machine shows promise in tumor control trial
NCT ID NCT06347731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new proton therapy device, the Varian ProBeam360°, in 47 people with solid tumors. The goal was to see if it could control tumor growth with few severe side effects. Participants received radiation for 1 to 8 weeks and were followed for up to 5 years. The main measure was disease control rate at 3 months, with a target of 80%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Proton radiation therapy (Varian ProBeam360° system)
- What this could lead to
- If successful, this could provide a more precise and safer radiation option for treating solid tumors, potentially reducing damage to healthy tissue.
- What could go wrong
- This is a small, single-center trial without a comparison group. The results may not apply to all patients or tumor types. Proton therapy is not new, so the main question is whether this specific device performs as well as existing systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN INTRACRANIAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New radiation approach aims to spare healthy tissue in sinus cancer treatment
- New nutrition strategy aims to protect kids with cancer from malnutrition
- New drug combo takes aim at Hard-to-Treat cancers
- New proton beam machine aims to improve cancer care
- Proton beam therapy shows promise in tumor control trial
- New iron injection shows promise in shrinking tumors